Delivery Order SPE2DE24D0013-SPE2D625F3GFW
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a $4,488 firm fixed-price delivery order to Cepheid Inc. on July 30, 2025, for SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. The delivery order, which carries an ultimate completion date of August 13, 2025, will be performed at Cepheid's headquarters in Sunnyvale, California. This award includes no set-aside designation and represents a near-term procurement from the Sunnyvale-based molecular...
- The U.S. Defense Department's Medical Supply Chain awarded a $11,404.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, for SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) testing supplies. The contract was awarded on September 8, 2025, with an ultimate completion date of September 19, 2025, and carries no small business set-aside designation. This delivery order will be performed at Cepheid's Sunnyvale facility...
- The U.S. Defense Medical Supply Chain awarded a $13.6K delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 2, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order (Contract No. 4569302261) procures diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a continuation of...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,080 to Cepheid Inc. for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. The delivery order, issued on August 22, 2025, with completion targeted for August 29, 2025, represents a continuation of the Medical Supply Chain's procurement of molecular diagnostic testing capabilities. Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems and...
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,835 firm fixed-price delivery order to Cepheid Inc. on August 29, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, which extends through September 8, 2025, will be performed at Cepheid's facility in Sunnyvale, California. This award carries no small business set-aside designation and represents a continuation of...
- The U.S. Defense Department's Medical Supply Chain awarded an $8,160 firm fixed-price delivery order to Cepheid Inc. on August 8, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, which carries an ultimate completion date of August 15, 2025, will be performed in Sunnyvale, California, where Cepheid maintains its headquarters. This award represents no set-aside designation and reflects the...
- The U.S. Defense Department's Medical Supply Chain awarded a $17,680 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The delivery order, designated XPCOV2/FLU/RSV-10, is set to be completed by September 15, 2025, with performance conducted at Cepheid's headquarters in Sunnyvale, California. This award carries no set-aside designation and represents a...
- The Defense Department's Medical Supply Chain division awarded Cepheid Inc. a $17,952 firm fixed-price delivery order on August 4, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract is set to be completed by August 18, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of the Defense Department's reliance on Cepheid's GeneXpert...
- The Defense Department's Medical Supply Chain awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic testing supplies and services related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract, designated as delivery order 4569460623, is scheduled for completion by September 19, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. This award carries no set-aside designation and represents routine...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,960 firm fixed-price delivery order to Cepheid Inc. on September 17, 2025, with an ultimate completion date of September 24, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits for infectious diseases,...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3GFWDelivery Order
The U.S. Department of Defense Medical Supply Chain awarded a $38,148 firm fixed-price delivery order to Cepheid Inc. for SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. The delivery order, issued on September 15, 2025, with an ultimate completion date of September 26, 2025, represents a continuation of Cepheid's ongoing provision of molecular diagnostic testing capabilities to federal healthcare systems. Cepheid, a Sunnyvale, California-based manufacturer of advanced diagnostic systems, will perform the work at its California headquarters. This award carries no set-aside designation, reflecting standard competitive procurement procedures. This delivery order likely derives from one of Cepheid's existing Indefinite Delivery Vehicle contracts, most notably the $32.8 million single-award IDV with the Veterans Affairs Veterans Integrated Service Network 6, which provides molecular diagnostic testing system reagents and assays through September 2030. The short completion timeline and modest contract value suggest this represents a discrete supply order for specific diagnostic reagents, cartridges, or related consumables required for multiplex respiratory pathogen testing. Cepheid's extensive federal contracting history with the VA, Defense Logistics Agency, and Defense Health Agency demonstrates its established role as a critical supplier of molecular diagnostics for infectious disease detection across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.1k | 9/15/25 |